U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06815354) titled 'Comprehensive Assessment of Cancer Theranostic Response' on Feb. 04.
Brief Summary: The intent of this study is to evaluate actionable outputs from TRAQinform Theranostics in a prospective, multi-center, non-interventional clinical study. The primary objective is to investigate intent-to-change treatment decisions after the addition of TRAQinform Theranostics. The exploratory objective is to investigate if treatment efficacy and treatment-related toxicity could be detected by TRAQinform Theranostics following PSMA PET/CT at week 12.
Study Start Date: Dec. 02, 2024
Study Type: OBSERVATIONAL
Condition:
Prostate Cancer
Intervention...